Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published:December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Next-gen sequencing identifies thousands of cancer patients missing out on immunotherapy December 28, 2023 Study finds association between pesticide exposure and stillbirth risk August 7, 2024 New advisory offers evidence-based strategies to prevent postoperative delirium in older adults December 10, 2024
Next-gen sequencing identifies thousands of cancer patients missing out on immunotherapy December 28, 2023
New advisory offers evidence-based strategies to prevent postoperative delirium in older adults December 10, 2024